ストックスクリーナーアプリを入手
8.67
0.46%
0.04
前日終値:
$8.63
開ける：
$8.58
24時間の取引高:
75,244
Relative Volume:
0.64
時価総額：
$125.00M
収益：
$166.88M
当期純損益:
$-74.18M
株価収益率:
-1.7101
EPS:
-5.07
ネットキャッシュフロー:
$1.14M
1週間 パフォーマンス:
-3.02%
1か月 パフォーマンス:
-0.57%
6か月 パフォーマンス:
-49.33%
1年 パフォーマンス:
-64.50%
1日の値動き範囲:
$8.52
$8.71
1週間の範囲:
$8.37
$9.0413
52週間の値動き範囲:
$7.8701
$26.00
Anika Therapeutics Inc Stock (ANIK) Company Profile
名前
Anika Therapeutics Inc
セクター
電話
(781) 457-9000
住所
32 WIGGINS AVENUE, BEDFORD, MA
ANIK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
8.67 | 121.11M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-17 | 開始されました | B. Riley Securities | Buy |
| 2024-11-01 | 繰り返されました | Barrington Research | Outperform |
| 2023-08-14 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | 再開されました | Stephens | Equal-Weight |
| 2022-03-09 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | 開始されました | Stephens | Overweight |
| 2021-07-16 | 開始されました | UBS | Neutral |
| 2020-12-16 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | アップグレード | Sidoti | Neutral → Buy |
| 2020-01-10 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | 開始されました | BWS Financial | Sell |
| 2019-09-24 | 繰り返されました | Barrington Research | Outperform |
| 2019-09-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | アップグレード | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | ダウングレード | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | ダウングレード | Sidoti | Buy → Neutral |
| 2018-07-27 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | 繰り返されました | Barrington Research | Outperform |
| 2016-05-09 | アップグレード | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | 繰り返されました | Barrington Research | Outperform |
すべてを表示
Anika Therapeutics Inc (ANIK) 最新ニュース
How to read the order book for Anika Therapeutics Inc.Share Buyback & Step-by-Step Trade Execution Guides - Newser
Real time breakdown of Anika Therapeutics Inc. stock performanceJuly 2025 Pullbacks & Weekly Top Gainers Alerts - Newser
What to expect from Anika Therapeutics Inc. in the next 30 daysGap Down & Fast Entry and Exit Trade Plans - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc.ANIK - FinancialContent
Cove Street Capital LLC Acquires New Position in Anika Therapeutics Inc. $ANIK - MarketBeat
Aug Patterns: Is Anika Therapeutics Inc. gaining market shareDividend Hike & Accurate Trade Setup Notifications - Lancaster City Council
Nuveen LLC Acquires Shares of 41,315 Anika Therapeutics Inc. $ANIK - MarketBeat
Anika Therapeutics Inc. Price Targets Raised After ReboundJuly 2025 Gainers & High Conviction Buy Zone Picks - beatles.ru
Reversal Confirmed Anika Therapeutics Inc. Stock Rallies Above MAJuly 2025 Movers & Fast Momentum Stock Entry Tips - beatles.ru
Published on: 2025-09-08 20:31:28 - beatles.ru
Trendline Breach Raises Concern for Anika Therapeutics Inc. Investors2025 Market Overview & Entry Point Confirmation Signals - beatles.ru
What is the target price for Anika Therapeutics Inc. stock2025 Price Targets & Consistent Profit Alerts - beatles.ru
Should you buy the dip on Anika Therapeutics Inc.July 2025 Catalysts & Safe Entry Trade Reports - beatles.ru
Will Anika Therapeutics Inc. rebound enough to break even2025 Bull vs Bear & Smart Money Movement Alerts - Newser
Statistical indicators supporting Anika Therapeutics Inc.’s strengthInsider Buying & Expert-Curated Trade Recommendations - Newser
What data driven models say about Anika Therapeutics Inc.’s futureQuarterly Profit Summary & Long Hold Capital Preservation Tips - Newser
How cyclical is Anika Therapeutics Inc.’s revenue stream2025 Technical Overview & Consistent Profit Alerts - خودرو بانک
Does Anika Therapeutics Inc. have declining or rising EPSStop Loss & Weekly High Conviction Trade Ideas - خودرو بانک
Risk adjusted return profile for Anika Therapeutics Inc. analyzedJuly 2025 Update & Free Real-Time Market Sentiment Alerts - Newser
Can Anika Therapeutics Inc. expand into new marketsPortfolio Performance Report & Fast Gain Stock Trading Tips - خودرو بانک
Visual analytics tools that track Anika Therapeutics Inc. performanceJobs Report & Smart Swing Trading Alerts - Newser
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Anika Therapeutics Announces Inducement Grants for New Hire Under Nasdaq Listing Rule 5635(c)(4) - AInvest
2,500 Shares at $9.15: Anika Therapeutics Awards Inducement Stock Options to New Non-Executive Hire - Stock Titan
Understanding Anika Therapeutics Inc.’s price movementJuly 2025 Highlights & Entry Point Confirmation Signals - Newser
Regression analysis insights on Anika Therapeutics Inc. performanceMarket Performance Report & Daily Entry Point Alerts - Newser
Price momentum metrics for Anika Therapeutics Inc. explainedPortfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Does Anika Therapeutics Inc. fit your quant trading modelJuly 2025 Intraday Action & Community Consensus Stock Picks - Newser
Pomerantz LLP Investigates Potential Claims Involving Anika Therapeutics Investors - geneonline.com
Published on: 2025-09-04 09:02:32 - Newser
Will Anika Therapeutics Inc. stock recover after recent dropMarket Rally & Free Risk Controlled Daily Trade Plans - Newser
Is Anika Therapeutics Inc. stock bottoming outJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
How hedge fund analytics apply to Anika Therapeutics Inc. stockFed Meeting & Risk Managed Investment Strategies - Newser
Sentiment analysis tools applied to Anika Therapeutics Inc.Weekly Trade Review & Daily Chart Pattern Signal Reports - Newser
Live market analysis of Anika Therapeutics Inc.Market Performance Recap & Verified Technical Trade Signals - Newser
Is Anika Therapeutics Inc. gaining market shareBreakout Watch & Fast Entry and Exit Trade Plans - خودرو بانک
How institutional ownership impacts Anika Therapeutics Inc. stock2025 Stock Rankings & Community Trade Idea Sharing Platform - Newser
Anika Therapeutics Inc. $ANIK Stake Boosted by HighTower Advisors LLC - Defense World
Will Anika Therapeutics Inc. price bounce be sustainableWeekly Trade Report & Free Safe Capital Growth Stock Tips - Newser
Is Anika Therapeutics Inc. stock entering bullish territoryMarket Movers & Advanced Swing Trade Entry Plans - Newser
Will Anika Therapeutics Inc. benefit from geopolitical trendsInsider Selling & Daily Profit Focused Screening - خودرو بانک
Real time scanner hits for Anika Therapeutics Inc. explainedQuarterly Market Review & Smart Allocation Stock Tips - Newser
Tools to monitor Anika Therapeutics Inc. recovery probabilityJuly 2025 Recap & Expert Curated Trade Ideas - Newser
Is Anika Therapeutics Inc. forming a bottoming base2025 Winners & Losers & Long-Term Growth Plans - Newser
What are Anika Therapeutics Inc.’s recent SEC filings showingRate Cut & Entry and Exit Point Strategies - خودرو بانک
Anika Therapeutics Inc (ANIK) 財務データ
収益
当期純利益
現金流量
EPS
Anika Therapeutics Inc (ANIK) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Nunes Anne | SVP, Chief Operations Officer |
Mar 17 '25 |
Option Exercise |
0.00 |
3,637 |
0 |
21,722 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 17 '25 |
Option Exercise |
0.00 |
6,448 |
0 |
49,847 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 17 '25 |
Option Exercise |
0.00 |
25,132 |
0 |
209,472 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 11 '25 |
Option Exercise |
0.00 |
2,561 |
0 |
18,837 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 11 '25 |
Option Exercise |
0.00 |
7,663 |
0 |
45,649 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 11 '25 |
Option Exercise |
0.00 |
30,060 |
0 |
197,015 |
| Nunes Anne | SVP, Chief Operations Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,296 |
0 |
17,235 |
| Colleran David | EVP, General Counsel, Corp Sec |
Mar 10 '25 |
Option Exercise |
0.00 |
5,465 |
0 |
39,590 |
| Blanchard Cheryl R | President, CEO, Director |
Mar 10 '25 |
Option Exercise |
0.00 |
20,002 |
0 |
172,826 |
| Nunes Anne | SVP, Chief Operations Officer |
Oct 01 '24 |
Option Exercise |
0.00 |
2,491 |
0 |
14,211 |
2.67%
0.04%
大文字化:
|
ボリューム (24 時間):